Tags

Type your tag names separated by a space and hit enter

ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    Mount Sinai Medical Center, New York, NY, USA.

    Source

    Annals of internal medicine 152:12 2010 Jun 15 pg JC6-10

    Pub Type(s)

    Comment
    Journal Article

    Language

    eng

    PubMed ID

    20547892

    Citation

    Farkouh, Michael. "ACP Journal Club. Nateglinide Did Not Reduce Diabetes or CV Events in Patients With Impaired Glucose Tolerance and CV Risk Factors." Annals of Internal Medicine, vol. 152, no. 12, 2010, pp. JC6-10.
    Farkouh M. ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors. Ann Intern Med. 2010;152(12):JC6-10.
    Farkouh, M. (2010). ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors. Annals of Internal Medicine, 152(12), pp. JC6-10. doi:10.7326/0003-4819-152-12-201006150-02010.
    Farkouh M. ACP Journal Club. Nateglinide Did Not Reduce Diabetes or CV Events in Patients With Impaired Glucose Tolerance and CV Risk Factors. Ann Intern Med. 2010 Jun 15;152(12):JC6-10. PubMed PMID: 20547892.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors. A1 - Farkouh,Michael, PY - 2010/6/16/entrez PY - 2010/6/16/pubmed PY - 2010/6/16/medline SP - JC6 EP - 10 JF - Annals of internal medicine JO - Ann. Intern. Med. VL - 152 IS - 12 SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/20547892/ACP_Journal_Club__Nateglinide_did_not_reduce_diabetes_or_CV_events_in_patients_with_impaired_glucose_tolerance_and_CV_risk_factors_ L2 - https://www.annals.org/article.aspx?doi=10.7326/0003-4819-152-12-201006150-02010 DB - PRIME DP - Unbound Medicine ER -